Pharmachologic Prophylaxis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis / 대한췌담도학회지
Korean Journal of Pancreas and Biliary Tract
;
: 148-167, 2021.
Article
in Korean
| WPRIM
| ID: wpr-902371
ABSTRACT
Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is one of the most burdensome adverse events, occurs in about 3 to 15 percent of patients after the procedure. Various and extensive attempts have been made to find proper prophylaxis for PEP. Nowadays, pharmacologic agents consist one of the pivotal axis for prophylaxis for PEP. In this review article, we tried to overview pharmacologic prophylaxis including non-steroidal anti-inflammatory drugs, aggressive hydration, protease inhibitors, exocrine pancreatic secretion inhibitors, and nitrates from recent updated results of randomized controlled studies and key meta-analyses.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Korean
Journal:
Korean Journal of Pancreas and Biliary Tract
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS